General Archives - Page 2328 of 2367

2 minute read

Lawmaker Warns San Francisco Faces ‘Public Health Mess’ Over Monkeypox Vaccine Shortage

July 14, 5:13 PM

A California state legislator representing the Bay Area declared San Francisco is "veering toward a public health mess" after the city’s Department of Public Health acknowledged it is running out of monkeypox vaccine and will have to shutter one of its clinics until the supply is replenished.

BVNRY

2 minute read

Keeping It In The Family? Elon’s Dad Errol Musk Had Unplanned Child With Stepdaughter

By AJ Fabino

July 14, 5:10 PM

News broke Wednesday that Errol Musk, 76, the father of the richest man in the world, Tesla Inc (NASDAQ: TSLA) CEO Elon Musk, had an unplanned child in 2019 with his stepdaughter, Jana Bezuidenhout, who is now 41 years old.

TSLA

1 minute read

Omega Therapeutics Gets FDA Nod For Initial-Stage Liver Cancer Study

By Ragothaman Srinivasan

July 14, 4:55 PM

The U.S. Food and Drug Administration (FDA) has announced clearance to Omega Therapeutics’ (NASDAQ: OMGA) Investigational New Drug (IND) to initiate a Phase 1/2 clinical study of its candidate OTX-2002 for the treatment of hepatocellular carcinoma (HCC).

OMGA

2 minute read

Apple, Microsoft, Tesla, Amazon Experience Record Losses, But Investors Remain Hopeful: Benzinga Survey

By Dylan Wechsler

July 14, 4:45 PM

In a recently conducted Benzinga survey, our users answered a question regarding where they see the SPDR S&P 500 ETF Trust (NYSE: SPY) closing at the end of the year.

AAPL

2 minute read

NexImmune Announces IND Clearance By US FDA For NEXI-003 For Treatment Of HPV-Related Cancers

By Bill Haddad

July 14, 4:12 PM

First IND for NexImmune's AIM nanoparticle platform in solid tumors IND clearance enables commencement of a clinical trial to evaluate NEXI-003, an autologous antigen-specific T cell product (CD3+/CD4-), in

NEXI

1 minute read

Oncternal Therapeutics Announces Clinical Trial Collaboration To Advance Zilovertamab Phase 3 Study In Combination With Ibrutinib For Patients With MCL

By Benzinga Newsdesk

July 14, 4:01 PM

Clinical trial collaboration supports global registrational Phase 3 study ZILO-301, to treat patients with relapsed or refractory MCL with zilovertamab plus ibrutinib Agreement is supportive of the planned initiation

ONCT